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Objective: To investigate the distribution of serogroups, serotypes and subtypes, and susceptibility t o  antibiotics, of 
75 strains isolated from patients with systemic meningococcal disease in Moscow in 1993-95. 
Results: In contrast t o  the situation in most European countries, 21% of group A strains were found. Sixty-nine per cent 
of the strains were non-serotypeable using the current panel of antibodies, and 21% of strains were non-subtypeable. 
Twenty-nine different serotype-subtype combinations were found among 69 strains of group A, B and C. No combination 
predominated clearly; relatively more frequent strains had the formulae B:NT:P1.2, A:4:P1.5,10 and C:4:P1.10. Recently, 
such strains have been very rare in western Europe; in  contrast, the strains predominating in western Europe were not 
found in Moscow. All strains were sensitive to penicillin, chloramphenicol and rifampicin. 
Conclusions: Moscow strains of Neisseria rneningitidis demonstrated a substantial diversity of serotypes and 
subtypes that probably corresponded to a post-epidemic situation in Russia. The obvious difference in circulating strains 
and presumably in immunity of populations in western Europe and Russia increases the probability of mutual exchange 
of pathogenic strains and stresses the need for group B vaccine protecting from both western and eastern European 
variants of meningococci. 
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INTRODUCTION 
Monitoring of capsular polysaccharides (serogrouping) 
and outer-membrane proteins (serotyping and sub- 
typing) of pathogenic meningococci is the basic 
method of epidemic surveillance. This provides the 
information required for development and application 
of meningococcal vaccines, since these polysaccharides 
and proteins are the major antigens of meningococci, 
and may thus control spread of strains. Another method 
of epidemiologic surveillance is the determination of 
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antimicrobial resistance in the pathogen. However, 
the distribution of meningococcal serogroups and, 
especially, serotypes and subtypes, and of antibiotic 
resistance in Russia, has not been systematically 
studied and reported. This involves a serious lack of 
global epidemiologic knowledge, since 3839 cases 
of systemic meningococcal infection were notified 
in Russia in 1995, corresponding to an incidence 
of 2.6 cases/100000 individuals per year. The real 
incidence may be twice as great, owing to diagnostic 
difficulties. The antigenic properties of meningococcal 
strains circulating in Russia may be different from those 
of other European strains, and the transfer of new 
strains to European populations that do not have 
appropriate inlmunity might result in epidemic out- 
breaks of the disease. According to Achtman [I], such 
an event might have taken place during the spread 
of an epidemic group A, subgroup 111, strain in the 
early 1970s in Scandinavia. This study concerns the 
distribution of serogroups, serotypes and subtypes of 
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strains causing meningococcal disease in 1993-95 in 
Moscow, when an incidence of 3.0/100 000 was notified. 
MATERIALS AND METHODS 
Strains and patients 
Seventy-five strains of Neisseria rneningitidis were 
isolated from patients admitted to the Second Moscow 
Hospital for Infectious Diseases in 1993 (second half- 
year), 1994 and 1995 (first half-year). Sixty strains were 
isolated from cerebrospinal fluid (CSF), 11 strains were 
isolated from blood, and four strains were isolated from 
both CSF and blood. Positive culture was obtained 
froni only about a quarter of patients who had the 
diagnosis of nieningococcal disease based on clinical 
and laboratory data. A probable reason was that, 
according to Russian recommendations, penicillin 
was administered to patients before microbiological 
sampling [2]. This practice, although beneficial for 
patients, decreases the number of positive cultures [3]. 
The age distribution of patients was typical for 
meningococcal disease in Russia. The median age was 
5 years, and the range from 2 months to 80 years; 45% 
of patients were younger than 5 years and a second 
small peak (11%) was observed in the 15-19-year age 
group. 
Typing of Neisseria meningitidis 
Serogrouping of capsular polysaccharide was done by 
the standard method of immune precipitation with 
specific sera [4,5]. Serotypes (the variants of class 2 or 
class 3 outer-membrane proteins) and subtypes (the 
variants of class 1 outer-membrane protein) were 
identified by whole cell ELISA [6] using the panel of 
monoclonal antibodies to serotypes 1,  2a, 2b, 4, 14, 15 
and 16 and subtypes P1.l ,  P1.2, P1.4, P1.5, P1.6, 
P1.7, P1.9, P1.lO, P1.12, P1.14, Pl.15 and P1.16. 
The monoclonals were manufactured by RIVM 
(National Institute of Public Health and Environmental 
Protection, Bilthoven, The Netherlands). 
Susceptibility to antibiotics 
Susceptibility to penicillin and chloramphenicol (all 
strains) and to rifanipicin (51 strains) was studied 
using the E-test (AB Biodisk, Sweden), according to 
the instructions of the manufacturer. The data were 
expressed as minimal inhibitory concentration (MIC) 
for each strain and agent. 
RESULTS 
Serogroups 
In the years in question serogroup €3 has always been 
predominant (56%, 42 isolates), although serogroups 
A and C were also present in approximately equal 
amounts: 21% (16 isolates) and 15% (11 isolates), 
respectively. Two strains of serogroup W135 were 
found; four strains were ungroupable. In 1993-95 the 
percentage of group A strains increased from 11% (two 
isolates in the second half of 1993) to 33% (seven 
isolates in the first half of 1995), and that of group 
B strains decreased correspondingly, from 67% (12 
isolates) to 43% (nine isolates). However, these changes 
did not reach statistical significance. 
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Figure 1 Age distribution by serogroups A, B and C. Strains were isolated from patients with nieningococcal disease in 
Moscow in 1993-95. Abscissa: Age range, years. Ordinate: Number of strains of a certain serogroup obtained from patients 
of a given age range. 
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The distribution of the different serogroups was 
age related, as shown in Figure 1. Group A cases 
prevailed in age groups of 5-14 and 25-44 years. The 
percentage age distribution of group B had a maximum 
in the youngest group of 0-4 years and another small 
peak in the older groups of 45-64 and > 65 years. As a 
result, group B disease predominated in these groups. 
No group C isolates were obtained from patients aged 
more than 45 years, but they were rather frequent in 
the 15-24-year age group. The difference in age 
distributions for group A and group B isolates, namely 
the prevalence of group B cases in infants and weak age 
dependence of group A cases, was significant according 
to Pearson statistics (xz= 15, p<O.Ol). The differences 
between A and C groups, and B and C groups, did not 
reach statistical significance. 
Serotypes and subtypes 
The serotype and subtype distributions are shown in 
Table 1. Of  42 group B strains, 34 (81%) were non- 
typeable using our standard panel of antibodies. Four 
strains (10%) were type 1. Ten (24%) of the group B 
strains were non-subtypeable. Subtypes P1.5,2 (24%), 
P1.14 (17%) and P1.5 (14%) were relatively frequent. 
Six other subtypes were encountered occasionally. 
Of  11 group C strains, eight (73%) were non- 
typeable. Two strains were type 4. Two (18%) of the 
group C strains were non-subtypeable. Subtypes P1.5,2 
(18%) and P1.10 (27%) were relatively frequent. There 
were four strains of four other subtypes. 
Group A meningococci were more homogeneous. 
Only five (31%) of the strains were non-typeable. The 
remaining 11 strains were type 4. One strain was non- 
subtypeable. Other subtypes were P1.10 (44%), P1.5,10 
(31%) and P1.9 (19%). 
One group W135 strain was type 4, and another 
was non-typeable; both strains were non-subtypeable. 
Ungroupable strains were non-typeable, and were 
subtype P1.5,2 (two strains), P1.6 (one strain) or non- 
subtypable (one strain). 
No serotype-subtype combination predominated 
substantially in any serogroup. The 4:P1.5,10 sero/ 
Table 1 Serotypes and subtypes of Neisseria rneningitidir strains received in Moscow 
Serotype 
Subtype 1 2a 2b 4 14 N T  Total 
Group A meningococci 
1.9 
1.10 
1.5,lO 
NST 
Total 
3 
3 
5 
11 (69%) 
3 (19%) 
5 (31%) 
4 7 (44%) 
1 1 (6%) 
5 (31%) 16 
1 
1 
2 (5%) 
Group B meningococci 
1.1,7 1 1 2 (5%) 
1.5 2 4 6 (14%) 
1.5,2 10 10 (24%) 
1.6 2 2 (5%) 
1.9 1 2 (5%) 
1.14,7 1 1 (2%) 
1.15 1 1 (2%) 
1.16 1 1 (2%) 
1.14 6 7 (17%) 
NST 1 9 10 (24%) 
Total 4 (10%) 1 (2%) 1 (2%) 34 (81%) 42 
Group C meningococci 
1.5.2 2 2 (18%) 
1.6 1 1 (9%) 
1.7 1 1 (9%) 
1.15,7 1 1(9%) 
1.16 1 1 (9%) 
Total 2 (18%) 1(9%) 8 (73%) 11 
1.10 2 1 3 (27%) 
NST I 1 2 (18%) 
NT, non-typeable; NST, non-subtypeable. 
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Table 2 Antibiotic susceptibilities of meningococcal strains cultured from patients with meningococcal disease in 1993-95 in 
Moscow 
~~ ~ 
Penicillin: Chlorarnphenicol: Rifampicin: 
number of strains number of strains number of rtrains 
Miiiiinal 
inhibitory 
concen- A 
trdtlon, Ing/L 
0.002 
0.006 
0.008 1 
0.012 2 
0.01 6 - 3
0.023 1 
0.032 4 
0.047 4 
0.064 1 
0.094 1 
0.125 
0.19 
0.38 
0.5 
0.75 
1 
1 5  
Meail MIC. 
U C W NG Total A €3 C W NG Total A B C W NG Total 
135 135 135 
2 2  
5 2 1 1  
16 4 1 
10 2 1 2 
7 1  
I 
1 1 
1 1 
1 4 1  3 
2 1 1 2  
6 7 5 1 1 1 4  
10 1 1  2 4  
2 i  7 6 
19 1 1 1  3 
9 1 4  6 
1 2 2 
1 1 3  J 
1 1  2 
1 1 
10 6 3 19 
4 2 4  7 1 3 39 
1 11 1 1 14 
1 1 
1 
subtype was more typical for group A (31%), NT:P1.5,2 
presented more frequently in group B (24%), and 
4:P1.10 strains were found twice among group C strains. 
No serotype, subtype or combination could be 
reliably attributed to patients of a particular age group. 
Susceptibility to antibiotics 
Susceptibilities of Moscow group A, B and C strains to 
penicillin (first-choice treatment of meningococcal 
disease), chloramphenicol (recommended in Russian 
practice for treatment of fulminant meningococcemia 
to limit the endotoxin release [2]) and rifampicin 
(reconmiended for prophylaxis of carriers and close 
contacts) are shown in Table 2. N o  resistant strain 
was found. Only a few strains could be considered to 
be moderately resistant, e.g. one group B strain with an 
MIC for penicdlin of 0.125 mg/L. The susceptibilities 
to penicillin and to chloramphenicol were slightly cor- 
related (coefficient of correlation 0.4, p <0.05). Group 
A strains were more susceptible to chloramphenicol and 
less susceptible to rifampicin in comparison to group B 
or C strains (one-way ANOVA, Student-Neuman- 
Keuls test, y< 0.05). N o  significant difference in resist- 
ance among different serotypes and subtypes was found. 
DISCUSSION 
The characteristics of strains causing meningococcal 
disease in Moscow are clearly different from that of 
those found in the rest of Europe. In 1994, European 
countries, excluding Russia, reported less than 25 
group A isolates among 3594 isolates, less than 1% [7]. 
In Moscow, group A meningococci were responsible 
for about 20% of cases, although group R disease 
predominated and group C strains were also seen. This 
kind of distribution has not been described in western 
Europe since the early 1980s, when group B disease 
started to increase in several countries and group A 
disease disappeared simultaneously in most regions 
[8,9]. A similar tendency was observed in Moscow, 
where group B disease peaked in 1984-88, when its 
incidence was about 4/100 000, and after that declined 
steadily to 1.3/100 000 in 1994. The group A epidemic 
had a maximum in 1970 (about 20 cases/l00000) and 
from 1982 to 1994 the incidence decreased from 
h/100100 to 0.5/100000. Thus group A disease did 
not disappear completely in Moscow but appears to 
have stabilized over the past several years. This means 
that Moscow, and Russia, are still the reservoirs of 
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pathogenic group A meningococci which, in un- 
favorable conditions, may start to spread again. 
The age distribution of group B cases in Moscow 
is similar to that in most European countries. The only 
exception is the relatively high proportion of cases 
(26%) in older age groups, >44  years. In western 
Europe this proportion never exceeds 15% [7]. The 
basis for this difference is unclear. A high proportion of 
cases (57%) in the youngest age group, < 5  years, is 
typical for current group B infection and may reflect 
the prolonged and intensive circulation of group B 
meningococci in certain regions, where most of the 
population already has natural immunity and only 
infants are susceptible. The age distribution of group 
A cases in Moscow may be compared only with 
historical data from European countries. It resembles 
the distribution in 1975-83 in England and Wales [8] 
as well as the distribution in 1980-86 in Moscow. The 
main feature of such a distribution is approximately 
equal numbers of cases in children (114  years) and 
adults (> 14 years). 
The studies of serotypes and subtypes of Moscow 
strains lead to three main conclusions. First, the panel 
of serotyping monoclonal antibodies developed in 
Europe and the USA is inappropriate for the typing 
of Russian isolates. In our series, 81% of group B 
strains and 73% of group C strains were untypeable 
in comparison to 15-35% in England [lo] or The 
Netherlands [9]. The same proportion of non-typeable 
strains was found among group B isolates obtained in 
Moscow in 1983-92 [ll]. Thus either additional 
nionoclonals specific for Russian strains should be 
produced or, preferably, genetic methods should be 
applied in a classification based on the class 2/class 3 
proteins of meningococci. Such methods use the 
amplification of variable regions of porin genes by the 
polymerase chain reaction followed by either the 
hybridization of product by specific probes or direct 
sequencing of amplicons [12-151. Group A strains were 
either type 4 or non-typeable, so the serotyping was not 
informative in classification of group A meningococci. 
Both the genetic approaches and new monoclonals to 
serotypes 21 and 22 are currently used to classify the 
Russian strains collected in 1996-97. 
Second, the set of subtypes (and serotypes) which 
was found among group B and C strains in Moscow 
was very wide and heterogeneous. Twenty-four different 
subtype-serotype combinations were found among 
53 strains. The real number of combinations could be 
even greater, because the group of non-typeable strains 
might be composed of different class 2/3 protein 
variants. For comparison, in The Netherlands, with 
approximately the same territory and population as 
the Moscow region, in 1994 there were observed only 
83 combinations for 475 group B and C isolates. If 
very rare serotype-subtype combinations were excluded 
(less than 2% of the total number), the difference would 
be even more substantial: 23 combinations for 475 
Dutch strains, i.e. nine times less than in Moscow. 
N o  combination was present in more than 25% of 
the total number of Moscow isolates, in contrast to 
many western European countries, where one or two 
combinations have clearly predominated [7,9,10,16]. 
Even for group A meningococci, five different sub- 
type-serotype combinations were found among 16 
Moscow strains, although usually only one group A 
clone predominated in a particular region [l]. The 
wide diversity of serotypes and subtypes probably 
corresponded to the post-epidemic situation in Russia. 
The great number of visitors and migrants to Moscow 
from the distant parts of Russian territories might 
enhance this striking diversity of meningococcal strains. 
Third, a limited number of outer-membrane 
protein combinations have frequently been found in 
Europe. In 1994 the most common combinations 
were B:15:P1.7,16 (Iceland, Denmark), B:NT:Pl.Q 
(England and Wales, Belgium), B:4:P1.4 (The 
Netherlands), B:4:P1.15 (Spain), B:2b:P1.10 (Scotland, 
Greece), C:2a:P1.2 (Czech Republic, Greece), 
C:2b:P1.10 (Eire), C:2a:P1.5 (England and Wales), 
C:2b:P1.2,5 (Spain), and C:2b:P1.2 (Scotland) [7]. 
(Unfortunately, the data from eastern European coun- 
tries are not available.) None of the above mentioned 
combinations was found even once in Moscow. Even 
ifwe take the second most common types into account 
and consider other countries with a lower incidence, 
no typical European combinations could be found in 
Moscow. Also, the relatively frequent Moscow strains 
such as B:NT:P1.2,5, B:NT:P1.14 and A.4:P.5,10 are 
practically absent in western Europe. Moscow strains 
do not coincide even with European carrier strains, 
which are usually more diverse 1171. These observa- 
tions highlight the differences in circulating strains and 
presumably in the immunity of populations in western 
Europe and Russia. This indicates the probability of 
exchange of pathogenic strains and stresses the need for 
group B vaccine protecting from both western and 
eastern European variants of meningococci. 
All strains of Neisseria meningitidis were sensitive 
to penicillin (MIC < 0.16 mg/mL), chloramphenicol 
(MIC<2 mg/mL) and rifampicin (MIC c0.25 mg/mJ-). 
So, although penicillin-resistant strains are present in 
Europe (9%) [7], particularly in Spain [18], they have 
not yet transferred to Moscow. Penicillin, chloram- 
phenicol and rifampicin remain the first-choice drugs 
for the treatment of systemic meningococcal disease 
and possible cases in close contacts and carriers, respec- 
tively 
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